Immunotherapy for cancer

Immunotherapy for cancer


Rights Managed


Immunotherapy for cancer: an autmomated machine adds nutrient medium to cell culture wells containing lymphocytes that have been doped with Interleukin-2 (IL-2). IL-2 is released naturally by certain key cells of the immune system (T- lymphocytes) after they have been activated by foreign antigens - of cancer cells, for instance. IL-2 amplifies the proliferation of other cell types, including lymphokine-activated natural killer (LANAK) cells that attack cancer cells directly. In this technique, blood is removed, doped with IL-2 & cultured in vitro for 3-4 weeks to raise the population of LANAK cells. The product is then re-injected into the patient. Photographed at Institut Gustave Roussy, Villejuif, France, 1989.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}